NVO logo

Novo Nordisk A/S (NVO) Long term liabilities

Annual long term liabilities:

$14.62B+$8.94B(+157.28%)
December 31, 2024

Summary

  • As of today (May 29, 2025), NVO annual total long term liabilities is $14.62 billion, with the most recent change of +$8.94 billion (+157.28%) on December 31, 2024.
  • During the last 3 years, NVO annual long term liabilities has risen by +$10.93 billion (+296.05%).
  • NVO annual long term liabilities is now at all-time high.

Performance

NVO Long term liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVObalance sheet metrics

quarterly long term liabilities:

$16.61B+$1.99B(+13.62%)
March 31, 2025

Summary

  • As of today (May 29, 2025), NVO quarterly total long term liabilities is $16.61 billion, with the most recent change of +$1.99 billion (+13.62%) on March 31, 2025.
  • Over the past year, NVO quarterly long term liabilities has increased by +$11.63 billion (+233.75%).
  • NVO quarterly long term liabilities is now at all-time high.

Performance

NVO quarterly long term liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVObalance sheet metrics

Long term liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

NVO Long term liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+157.3%+233.8%
3 y3 years+296.1%+216.4%
5 y5 years+979.1%+1197.2%

NVO Long term liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+296.1%at high+250.1%
5 y5-yearat high+979.1%at high+1197.2%
alltimeall timeat high>+9999.0%at high>+9999.0%

NVO Long term liabilities History

DateAnnualQuarterly
Mar 2025
-
$16.61B(+13.6%)
Dec 2024
$14.62B(+157.3%)
$14.62B(+42.4%)
Sep 2024
-
$10.27B(+3.7%)
Jun 2024
-
$9.90B(+98.9%)
Mar 2024
-
$4.98B(-12.4%)
Dec 2023
$5.68B(+7.2%)
$5.68B(+16.1%)
Sep 2023
-
$4.89B(-0.4%)
Jun 2023
-
$4.91B(-12.1%)
Mar 2023
-
$5.59B(+5.5%)
Dec 2022
$5.30B(+43.6%)
$5.30B(+11.7%)
Sep 2022
-
$4.74B(-2.9%)
Jun 2022
-
$4.89B(-6.9%)
Mar 2022
-
$5.25B(+42.2%)
Dec 2021
$3.69B(+97.2%)
$3.69B(+20.4%)
Sep 2021
-
$3.06B(-3.0%)
Jun 2021
-
$3.16B(+90.7%)
Mar 2021
-
$1.66B(-11.5%)
Dec 2020
$1.87B(+38.2%)
$1.87B(+25.9%)
Sep 2020
-
$1.49B(+12.2%)
Jun 2020
-
$1.32B(+3.5%)
Mar 2020
-
$1.28B(-5.5%)
Dec 2019
$1.35B(+85.5%)
$1.35B(+4.2%)
Sep 2019
-
$1.30B(+3.7%)
Jun 2019
-
$1.25B(+3.6%)
Mar 2019
-
$1.21B(+65.8%)
Dec 2018
$730.10M(-17.4%)
$730.10M(-5.4%)
Sep 2018
-
$771.42M(-0.3%)
Jun 2018
-
$773.74M(-9.2%)
Mar 2018
-
$851.73M(-3.6%)
Dec 2017
$883.75M(+28.6%)
$883.75M(-4.0%)
Sep 2017
-
$920.87M(+7.6%)
Jun 2017
-
$856.06M(+19.0%)
Mar 2017
-
$719.54M(+4.7%)
Dec 2016
$687.44M(+18.6%)
$687.44M(+3.3%)
Sep 2016
-
$665.36M(+7.1%)
Jun 2016
-
$621.41M(+1.9%)
Mar 2016
-
$609.68M(+5.2%)
Dec 2015
$579.62M(+15.3%)
$579.62M(+7.8%)
Sep 2015
-
$537.44M(-0.9%)
Jun 2015
-
$542.54M(+11.4%)
Mar 2015
-
$487.10M(-3.1%)
Dec 2014
$502.71M(-23.3%)
$502.71M(-10.2%)
Sep 2014
-
$559.96M(-6.5%)
Jun 2014
-
$598.61M(-0.3%)
Mar 2014
-
$600.45M(-8.4%)
Dec 2013
$655.77M(+8.9%)
$655.77M(+8.2%)
Sep 2013
-
$606.12M(-1.2%)
Jun 2013
-
$613.65M(+18.2%)
Mar 2013
-
$519.05M(-13.8%)
Dec 2012
$602.44M
$602.44M(-26.5%)
Sep 2012
-
$819.69M(-15.4%)
Jun 2012
-
$969.18M(-21.0%)
DateAnnualQuarterly
Mar 2012
-
$1.23B(+8.8%)
Dec 2011
$1.13B(+6.0%)
$1.13B(-0.8%)
Sep 2011
-
$1.14B(-1.7%)
Jun 2011
-
$1.16B(+2.2%)
Mar 2011
-
$1.13B(+6.4%)
Dec 2010
$1.06B(-1.2%)
$1.06B(-2.5%)
Sep 2010
-
$1.09B(+29.7%)
Jun 2010
-
$841.27M(-18.9%)
Mar 2010
-
$1.04B(-3.6%)
Dec 2009
$1.08B(+22.5%)
$1.08B(+14.4%)
Sep 2009
-
$940.47M(+6.5%)
Jun 2009
-
$883.03M(+5.3%)
Mar 2009
-
$838.90M(-4.5%)
Dec 2008
$878.35M(-8.6%)
$878.35M(+3.4%)
Sep 2008
-
$849.20M(-8.8%)
Jun 2008
-
$931.52M(-5.7%)
Mar 2008
-
$988.29M(+2.8%)
Dec 2007
$961.09M(+23.3%)
$961.09M(+11.8%)
Sep 2007
-
$859.52M(+10.3%)
Jun 2007
-
$779.00M(-1.5%)
Mar 2007
-
$791.00M(+1.5%)
Dec 2006
$779.55M(+31.5%)
$779.55M(+15.5%)
Sep 2006
-
$675.00M(-1.8%)
Jun 2006
-
$687.42M(+12.8%)
Mar 2006
-
$609.33M(+2.8%)
Dec 2005
$593.00M(-11.4%)
$593.00M(-13.8%)
Sep 2005
-
$687.62M(+34.2%)
Jun 2005
-
$512.26M(-11.6%)
Mar 2005
-
$579.32M(-13.4%)
Dec 2004
$669.34M(+55.3%)
$669.34M(+51.1%)
Sep 2004
-
$443.10M(+2.4%)
Jun 2004
-
$432.52M(-6.3%)
Mar 2004
-
$461.69M(+7.1%)
Dec 2003
$431.01M(+17.5%)
$431.01M(+17.5%)
Dec 2002
$366.68M(+12.2%)
$366.68M(+12.2%)
Dec 2001
$326.71M(+7.8%)
$326.71M(+7.8%)
Dec 2000
$303.03M(-0.8%)
$303.03M(-0.8%)
Dec 1999
$305.33M(-49.0%)
$305.33M(-49.0%)
Dec 1998
$598.57M(+85.7%)
$598.57M(+85.7%)
Dec 1997
$322.29M(+41.8%)
$322.29M(+41.8%)
Dec 1996
$227.23M(-29.4%)
$227.23M(-29.4%)
Dec 1995
$322.08M(-42.7%)
$322.08M(-42.7%)
Dec 1994
$561.81M(+5.8%)
$561.81M(+5.8%)
Dec 1993
$530.95M(+18.8%)
$530.95M(+18.8%)
Dec 1992
$447.01M(+38.1%)
$447.01M(+38.1%)
Dec 1991
$323.71M(+43.6%)
$323.71M(+43.6%)
Dec 1990
$225.37M(-15.0%)
$225.37M(-15.0%)
Dec 1989
$265.19M(+87.6%)
$265.19M(+87.6%)
Dec 1988
$141.34M(-12.3%)
$141.34M(-12.3%)
Dec 1987
$161.14M(-37.0%)
$161.14M(-37.0%)
Dec 1986
$255.73M(+171.9%)
$255.73M(+171.9%)
Dec 1985
$94.04M(+58.7%)
$94.04M(+58.7%)
Dec 1984
$59.27M
$59.27M

FAQ

  • What is Novo Nordisk A/S annual total long term liabilities?
  • What is the all time high annual long term liabilities for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual long term liabilities year-on-year change?
  • What is Novo Nordisk A/S quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly long term liabilities year-on-year change?

What is Novo Nordisk A/S annual total long term liabilities?

The current annual long term liabilities of NVO is $14.62B

What is the all time high annual long term liabilities for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual total long term liabilities is $14.62B

What is Novo Nordisk A/S annual long term liabilities year-on-year change?

Over the past year, NVO annual total long term liabilities has changed by +$8.94B (+157.28%)

What is Novo Nordisk A/S quarterly total long term liabilities?

The current quarterly long term liabilities of NVO is $16.61B

What is the all time high quarterly long term liabilities for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly total long term liabilities is $16.61B

What is Novo Nordisk A/S quarterly long term liabilities year-on-year change?

Over the past year, NVO quarterly total long term liabilities has changed by +$11.63B (+233.75%)
On this page